Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Herbert Tilg

Showing results (11-20 of 413) with videos related to

Pageof 42
Sort By:
Gastroenterology|June 26, 2017
How to Approach a Patient With Nonalcoholic Fatty Liver DiseaseHerbert Tilg
Gastroenterology|November 30, 2010
Abdominal pain beyond IBS. Hereditary angioedema (HAE type III)Werner Vogetseder, Herbert Tilg
Expert Opinion on Therapeutic Targets|April 16, 2008
Novel therapeutic targets in the treatment of IBDArthur Kaser, Herbert Tilg
Wiener Medizinische Wochenschrift (1946)|July 12, 2013
[Management of severe alcoholic hepatitis]Verena Wieser, Herbert Tilg
Expert Opinion on Biological Therapy|October 22, 2002
Antitumour necrosis factor therapy in Crohn's diseaseHerbert Tilg, Arthur Kaser
Expert Opinion on Biological Therapy|April 23, 2004
Type I interferons and their therapeutic role in Th2-regulated inflammatory disordersHerbert Tilg, Arthur Kaser
The Journal of Clinical Investigation|June 3, 2011
Gut microbiome, obesity, and metabolic dysfunctionHerbert Tilg, Arthur Kaser
United European Gastroenterology Journal|June 12, 2014
UEG Week Vienna 2014 cutting edge symposium: Today's Science, Tomorrow's Medicine session features the immune system - a driving force in digestive health and diseaseHerbert Tilg, Heiner Wedemeyer
Gastroenterology|August 3, 2020
How to Manage Crohn's Disease After Ileocolonic Resection?Herbert Tilg, Geert D'Haens
Nature Metabolism|January 10, 2025
TM6SF2 as new intestinal lipid playerHerbert Tilg, Christoph Grander
Pageof 42

Showing results (11-20 of 413) with videos related to

Sort By:
Pageof 42
Gastroenterology|June 26, 2017
How to Approach a Patient With Nonalcoholic Fatty Liver DiseaseHerbert Tilg
Gastroenterology|November 30, 2010
Abdominal pain beyond IBS. Hereditary angioedema (HAE type III)Werner Vogetseder, Herbert Tilg
Expert Opinion on Therapeutic Targets|April 16, 2008
Novel therapeutic targets in the treatment of IBDArthur Kaser, Herbert Tilg
Wiener Medizinische Wochenschrift (1946)|July 12, 2013
[Management of severe alcoholic hepatitis]Verena Wieser, Herbert Tilg
Expert Opinion on Biological Therapy|October 22, 2002
Antitumour necrosis factor therapy in Crohn's diseaseHerbert Tilg, Arthur Kaser
Expert Opinion on Biological Therapy|April 23, 2004
Type I interferons and their therapeutic role in Th2-regulated inflammatory disordersHerbert Tilg, Arthur Kaser
The Journal of Clinical Investigation|June 3, 2011
Gut microbiome, obesity, and metabolic dysfunctionHerbert Tilg, Arthur Kaser
United European Gastroenterology Journal|June 12, 2014
UEG Week Vienna 2014 cutting edge symposium: Today's Science, Tomorrow's Medicine session features the immune system - a driving force in digestive health and diseaseHerbert Tilg, Heiner Wedemeyer
Gastroenterology|August 3, 2020
How to Manage Crohn's Disease After Ileocolonic Resection?Herbert Tilg, Geert D'Haens
Nature Metabolism|January 10, 2025
TM6SF2 as new intestinal lipid playerHerbert Tilg, Christoph Grander
Pageof 42